Stakeholders have called for free testing and treatment of Viral Hepatitis (VH) in Nigeria by capturing it under the Basic Health Care Provision Fund or the National Health Insurance Act.
The stakeholders appealed at a meeting organized by the Federal Ministry of Health (FMoH) in collaboration with the Society for Family Health (SFH), Drug-Free and Presentation Healthcare Organisation (DAPHO), and Education As a Vaccine (EVA) through funding support from UNITAID.
Dr Ganiyu Jamiyu, the Deputy Director, Viral Hepatitis Desk, National AIDS and STIs Control Programme (NASCP), FMoH, said Nigeria’s prevalence rate of 8.1 percent for Hepatitis B Virus (HBV) and 1.1 percent for Hepatitis C Virus (HCV), was disturbing.
Jamiyu said at the project inception meeting on the Hepatitis C Prevention Combination Project (HEPC3P), that the situation persists because of limited access to VH services resulting from the high cost of testing and treatment.
He said though recent market-shaping efforts yielded 50 percent significant price reductions of diagnostic and treatment commodities, more still needs to be done as diagnosis and treatment of HBV and HCV is not within the reach of most Nigerians.
Jamiyu said that there should be sustained advocacy for more funding of VH control programs and increased awareness through sustainable mass media and community campaigns.
“Scale-up VH screening among key population and hard to reach areas in states and strengthening of referral system for VH patients.”
He said efforts by the Federal Government to scale up the response to the disease included the establishment of the National VH Control Programme in 2013, the inauguration of the National Technical Working Group (TWG), and the development of a national policy on VH in 2015.
Others are the National Programme on Immunisation which started in 2004, and Injection Control and Blood Safety which ensured that since 2005, Nigeria has routinely screened all donated blood and blood products for HBV and HCV.
“Injection safety policy including universal precaution existed since 2007 and is implemented in most government facilities.
“Establishment of the National Blood Service Commission (NBSC) to coordinate, regulate and ensure the provision of quality blood, blood products and services (2021),” he added.
The National Coordinator of NASCP, Dr. Adebobola Bashorun, said that VH means infective hepatitis that is transmitted through viruses and that about 19 million Nigerians were living with both diseases.
He said there were different VHs but the key ones are hepatitis B, C, and E viruses.
According to him, Nigeria has a national program that is looking at every VH infection.
“So in that national program, which started about 10 years ago, we have a national guideline that tells us what we should do in terms of prevention, treatments, and immunizations because it is an immunization-preventable disease, especially hepatitis B.
“So hepatitis C can be treated and that is a plus while the others cannot be treated but be controlled and managed so the country sees treatment as a priority for those that have been infected while we still try very hard to prevent people from getting infected.
“As a country, we have a robust guideline that starts from control in the population, prevention so that people can’t be affected, tests for infected persons, and treatments for hepatitis C which can be cured.”
Bashorun added that the viruses are blood-related infections through either the sharing of needles or sexual practices.
Dr Oluwafunke Odunlade, the Technical Officer of HIV and VH, World Health Organisation (WHO) Country Office in Nigeria, said that the meeting was to chart ways to prevent hepatitis C among people who inject drugs.
She said the advocacies and implementation of programs target different populations as vaccination focuses on prevention in children while some others focus on managing or treating the diseases for older populations.
“We are addressing different populations to ensure that we work on what affects them most, that is why the focus for viral hepatitis B prevention is on children.
“Now for People Who Inject Drugs (PWID), the practice of injection drugs, they exchange needles and HVC is common amongst them.
“That is why what we are doing today is to address HVC among them.
“Thankfully, it is a population group that you can contain in the sense that you can map them, you know the PWIDs and they are not as large as the general population that is why we are working with them,” she said.
Odunlade said that a lot was being done on blood transfusion, adding that hospitals are mandated to ensure that blood for transfusion is screened for Hepatitis B and C, HIV, and some other diseases.
She, however, said that the challenge being experienced with hepatitis was diagnostics and treatments because they are quite expensive.
“Most of our health services are being provided for out-of-pocket. If we go to the hospital, we pay even if we have health insurance, but basically, it is still out-of-pocket.
“So it is expensive to get a diagnosis and to have the different tests that you need to do, you would need up to N50,000.
“So this is where the challenges are but the country is not resting on its oars as the Federal Government is working together with the various stakeholders to address this particular area,” she added.
The Practice Lead, Society for Family Health (SFH), Mr. Godpower Omoregie, explained that the meeting was aimed at soliciting support from the national and state actors for an enabling environment for protocol development and the overall project implementation.
He added that it is to catalyze and enhance the visibility of the national response to VH and facilitate an active sense of ownership by the government for its sustainability beyond the project implementation.
He also said the meeting would provide a national platform for initiating active and ongoing engagement between implementing partners, community members, and other stakeholders.
A 25-member committee was inaugurated at the meeting as the National Community Advisory Board (CAB) on HEPC3P with Dr Bashorun of NASCP as the chairman.
